The impact of the 2007–2008 crisis on NBA attendance
International Business and Global Economy · 2022
DOI: 10.26881/ibage.2022.41.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Business and Global Economy, 2022. Verfasst von Stamatiki-Maria Atsave.
Abstract (Originalsprache)
Consumer behaviour is shaped by a number of parameters. One such parameter is the state of the economy and the level of disposable income, as the demand for goods is shaped according to the circumstances and the type of good. This paper examines whether the economic crisis of 2007–2009 had an impact on the number of spectators of the NBA games. The analysis examines, as well, whether some teams are more recession-proof than others. In order to establish the above, an econometric analysis has been conducted, having as independent variables the GDP, the real disposable income and the ranking position of the teams, and as a dependent variable the numer of tickets. Correlation analysis has being conducted, while a multiple regression analysis has been performed. The results show that the number of tickets has a correlation with GDP. The regression analysis shows that the ranking position is an explanatory variable of the number of tickets, while unemployment is not a statistically significant factor. As a conclusion, the analysis shows that recession has a negative impact on the number of tickets, while the ranking position of the team plays a significant role on the number of spectators.
Zitieren
APA
Atsave, S. (2022). The impact of the 2007–2008 crisis on NBA attendance. International Business and Global Economy. https://doi.org/10.26881/ibage.2022.41.02
Vancouver
Atsave S. The impact of the 2007–2008 crisis on NBA attendance. International Business and Global Economy. 2022. doi:10.26881/ibage.2022.41.02
BibTeX
@article{Atsave2022,
author = {Atsave, Stamatiki-Maria},
title = {The impact of the 2007–2008 crisis on NBA attendance},
journal = {International Business and Global Economy},
year = {2022},
doi = {10.26881/ibage.2022.41.02}
}
EUVIMED